Author Device ICU stay Hospital Implant Complications All-cause mortality (mean/ stay successa PV leak Permanent Stroke Renal Bleeding In-hospital Follow-up median (mean/ (severity) pacemaker failure/ complications (period) days) median implant dialysis days) Folliguet et al Perceval S (n NR NR 96% 8% NR 1% 6% requiring tx 2.4% 9.6% (2012) () = 208) (majorc) (other TE 4%) (mean 10mo) Gilmanov et al Perceval S (n 1.5 7 100% 1.5% 4% 2% (mild 5% requiring 0 0.7% (2013)()e = 137) dysfunction revision noncardiac (mild) 4%) (median 6mo) Santarpino Perceval S (n NR 11 99% 1% 4% 2% 1% major 2.4% 4.8% et al (2012)() = 83) bleedb (major (mean 3/4+) 1% fatal GI 8mo) bleed Shrestha et Perceval S 9 n NR NR 96% 2% 7% 1% NR 3% 11% al (2011)() = 180) (>2+ (30 day) (median mod/major) 1y) Zannis et al Perceval S (n NR NR 99% 3% 5% 1% NR 4.3% 10% (2012)() = 140) (majord) (1y)
Author Device ICU stay (mean/ median days) Hospital stay (mean/ median days) Implant successa Complications All-cause mortality PV leak (severity) Permanent pacemaker implant Stroke Renal failure/ dialysis Bleeding complications In-hospital Follow-up (period) Folliguet et al (2012) () Perceval S (n = 208) NR NR 96% 8% (majorc) NR 1% (other TE 4%) 6% requiring tx 2.4% 9.6% (mean 10mo) Gilmanov et al (2013)()e Perceval S (n = 137) 1.5 7 100% 1.5% (mild) 4% 2% (mild dysfunction 4%) 5% requiring revision 0 0.7% noncardiac (median 6mo) Santarpino et al (2012)() Perceval S (n = 83) NR 11 99% 1% (major 3/4+) 4% 2% 1% major bleedb 1% fatal GI bleed 2.4% 4.8% (mean 8mo) Shrestha et al (2011)() Perceval S 9 n = 180) NR NR 96% 2% (>2+ mod/major) 7% 1% NR 3% (30 day) 11% (median 1y) Zannis et al (2012)() Perceval S (n = 140) NR NR 99% 3% (majord) 5% 1% NR 4.3% 10% (1y)